Startups
2021
ACCURE THERAPEUTICS SLThe future of Central nervous system (CNS) treatments, today
A distinct approach to CNS drug development
A distinct approach to CNS drug development
Address
Carrer de Baldiri Reixac 15, 08028 Barcelona, Spain
Finance Data
CERCA ownership
Barcelona, Spain
2005
Institut de Recerca Biomèdica (IRB Barcelona)
CERCA Center Contact
CH
Cristina Horcajada
Institut de Recerca Biomèdica (IRB Barcelona)Other Catalan Public owners
Logo
Status & Deeptech areas
Company Status & Company Deeptech AreasCurrent company status
DeepTech Area
Spinoff information
Company Description
Accure Therapeutics is a R&D pharma company dedicated to developing innovative medicines to treat patients suffering from Central nervous system (CNS) diseases, a major medical challenge.
Accure Therapeutics focuses on neurons that suffer a dysfunction, and on the glial environment that supports them, in an attempt to impede their degeneration and death. We work to find new medicines that correct the pathological changes that are responsible for the disease, and that produce beneficial outcomes (i.e. Disease Modifying Therapies). We specialize in developing drugs that promote neuroprotection and neurorepair by integrating the latest advances in neurobiology with state-of-the-art clinical research.
Accure Therapeutics focuses on neurons that suffer a dysfunction, and on the glial environment that supports them, in an attempt to impede their degeneration and death. We work to find new medicines that correct the pathological changes that are responsible for the disease, and that produce beneficial outcomes (i.e. Disease Modifying Therapies). We specialize in developing drugs that promote neuroprotection and neurorepair by integrating the latest advances in neurobiology with state-of-the-art clinical research.
Product description
We support a targeted pipeline: We have currently built up a drug candidate portfolio that focuses on four areas:
Optic Neuritis
Multiple Sclerosis
Parkinson’s Disease
Epilepsy.
Optic Neuritis
Multiple Sclerosis
Parkinson’s Disease
Epilepsy.